Two Sigma Investments, LP Dice Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $320,664 - $579,204	12,400 Added 53.45%	35,600 $1.65 Million
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $1.44 Million - $1.79 Million	-55,390 Reduced 70.48%	23,200 $664,000
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $1.55 Million - $3.32 Million	78,590 New	78,590 $2.45 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.